Acute & General Medicine, 21- 22 November 2017, EXCEL LONDON

EUROPE’S MUST ATTEND CLINICAL TRAINING
CONFERENCE FOR ALL HOSPITAL DOCTORS 

12-13 NOVEMBER 2019, EXCEL LONDON

Advert
HOSTING THE 

EUROPEAN MEDICAL ASSOCIATION
ANNUAL CONFERENCE

HOSTING THE EUROPEAN ACUTE CARE CONFERENCE

EACC

hero

Exhibitors

Correvio

Stand: G30

Correvio commercializes brands for acute care. The anti-infective portfolio includes: Xydalba™ (dalbavancin), for the treatment ABSSSI; Zevtera® (ceftobiprole), for the treatment of CAP& HAP. The UK portfolio also includes cardiovascular products: Brinavess® (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm, and Aggrastat® (tirofiban hydrochloride) 

Address

Lakeside House
1 Furzeground Way,
Stockley Park
Uxbridge
UB11 1BD
United Kingdom

Website

http://www.correvio.com
Contact Exhibitor

Contact Exhibitor


Loading
  • Brinavess US Update

    28 October 2018 Correvio Correvio

    Based on productive pre-NDA discussions with the U.S. Food and Drug Administration (FDA), Correvio plans to resubmit the Brinavess® (vernakalant hydrochloride, IV) New Drug Application (NDA) during the second quarter of 2019. Brinavess® is Correvio’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF). The FDA agreed that no additional studies would be required for the resubmission of the NDA. 

  • Brinavess Data (Spectrum Study)

    05 September 2018 Correvio Correvio

    Correvio Pharma Corp. (NASDAQ: CORV) today reported preliminary data from SPECTRUM, a post-authorization safety study evaluating Brinavess (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), conducted in the European Union (EU).

2 Results
Loading
View all Exhibitors

Book your clinical Training pass

Early bird

Spring Release

   

Summer release

      

Autumn release

     

Training pass image

Supporters, partners & Sponsors

Gold sponsors

Silver sponsors

 

Registration sponsor

NHS Supporters

Media partners